Stay informed Sign up for our newsletter and be the first to know.
Stay informed Sign up for our newsletter and be the first to know.
Brilliant Investment Thinking by Advisers for Advisers.
ASX
-0.14%
S&P
-0.37%
AUD
$0.70

Growth Assets

Share
Print

The queue that isn’t forming: why Australia’s IPO market has stalled

The queue that isn’t forming: why Australia’s IPO market has stalled
Share
Print

Katie Hudson, head of Australian equities research at Yarra Capital Management, argues that the IPO drought gripping listed markets is not a demand problem, it is a valuation problem, and private capital is at the heart of it.

There is no shortage of appetite for quality new listings. Advisers want them, fund managers want them, and investors hungry for growth exposure in the listed market want them. What has gone missing is supply.

For Katie Hudson, who has spent nearly two decades in Australian small caps, the explanation is less mysterious than it might appear.

“There’s very strong demand for quality IPOs,” Hudson says. “We just haven’t seen the supply. And I think the reason for that is there’s so much private capital money around. There’s so much money now sitting in private capital hands that the need to come to listed equity markets hasn’t been there.”

For a market that has long relied on a steady pipeline of emerging companies to replenish the listed universe, that dynamic has real consequences. The small cap sector in particular depends on new entrants.

Founder-led businesses graduating from private ownership, fast-growing companies seeking a public currency for acquisitions, or established private enterprises looking to unlock value for early investors. When that pipeline dries up, the opportunity set narrows.

The valuation gap

At the centre of Hudson’s analysis is a structural disconnect between how private markets price assets and how public markets do. Listed markets reset valuations quickly and visibly. When sentiment shifts, prices move, and sometimes violently. Private markets, operating without that continuous price discovery, have been slower to adjust.

“Public markets have a valuation reset that can be rapid and very efficient,” she says. “Private markets don’t tend to have that efficient valuation reset. And I think to the extent that hasn’t happened, it has meant there hasn’t been the opportunity for them to then progress to the public markets, because they haven’t reset the valuations in the way that the public markets would like to see.”

The logic is straightforward. A company holding a private market valuation set in more exuberant conditions has little incentive to accept what a public market listing would value it at today. Better to wait, lean on existing private capital backers, and hope conditions improve.

That calculus has kept a cohort of potentially listable companies on the sidelines for longer than would historically have been the case.

“Why would you come to public markets when you’ve got these amazing valuations that private markets have been giving you, and an abundance of capital? It’s really only when you have the liquidity moment that that becomes an issue.”

The liquidity illusion

Hudson believes the calculation is beginning to shift, albeit slowly. The abundance of private capital that has sustained high valuations away from the listed market is not unlimited, and the one thing private capital cannot reliably manufacture is liquidity on demand.

“I suspect we’re moving into a phase where liquidity will be more valued again than it has been historically,” she says. “Obviously the problems that the US is having in some areas of private capital, locking up some money, I think people are recognising and realising that actually this money has a liquidity barrier with it.”

It is a point that cuts to the heart of a broader conversation playing out across the wealth industry. The appeal of private capital has been built, in part, on a narrative of superior returns and lower volatility. But the corollary, that investors surrender their ability to exit when they choose, has received less attention during years when distributions were flowing freely.

With exit activity slower and lock-up periods becoming more visible, the premium on liquidity is reasserting itself.

Not a structural problem

Hudson is careful to distinguish between a cyclical drought and a permanent structural decline.

The question of whether listing in Australia is simply less attractive than it used to be, given the compliance burden, the scrutiny of institutional investors, and the preference of founders to remain answerable to one private equity manager rather than a diffuse public shareholder base, is one she hears often. She takes the concern seriously, but she does not share it entirely.

“There’s definitely an element of that,” she acknowledges. “But I think people have probably understated the benefit of liquidity over the last three or four years, because there has been so much private capital money available.”

The implication is that the IPO market is not broken. It is waiting. Companies that have benefited from generous private valuations and easy access to capital have simply not yet reached the point where the listed market offers them something they cannot get elsewhere.

When liquidity becomes scarce, when private capital becomes more selective, or when valuations in the private market finally converge toward listed market equivalents, then the pipeline should begin to flow again.

What it means for small caps

For those investing in the listed small cap market, the drought has a practical edge. Having fewer new entrants means fewer opportunities to participate in a company’s high-growth phase from early in its listed life.

The kind of participation that Hudson points to as one of the defining attractions of the asset class. The ability to own Cochlear or CSL when they were genuinely small, before the compounding of decades had made them ASX fixtures, is precisely the kind of return profile that justifies a long-term allocation to active small cap management.

Yarra’s structure provides some insulation. Its pre-IPO private capital fund observes companies well before they reach the listed market, building corporate history and insight that translates directly into an advantage when those companies eventually do list. It is a partial answer to a structural problem. But it is not a substitute for a healthy IPO pipeline.

“You’re capturing that high growth period for the company,” Hudson says of the small cap opportunity more broadly. “You can capture that Cochlear or CSL when it’s on its big growth journey, before it becomes an ASX 50 company, when it’s in its high growth phase. And being able to be part of that and be the equity holder of that is pretty exciting.”

The problem, right now, is that not enough of those companies are choosing to make the journey at all. Until the valuation gap closes and the liquidity premium reasserts itself more forcefully, the queue outside the listing venue will remain shorter than the market would like.

Share
Print